Repare Therapeutics (RPTX) Earnings Date & Reports
A.I. Advisor
published Earnings
RPTX is expected to report earnings to rise 7.17% to -87 cents per share on November 06
Q3'24
Est.
$-0.88
Q2'24
Beat
by $0.05
Q1'24
Beat
by $0.28
Q4'23
Missed
by $0.31
Q3'23
Beat
by $0.41
The last earnings report on August 06 showed earnings per share of -81 cents, beating the estimate of -87 cents. With 54.71K shares outstanding, the current market capitalization sits at 146.01M.
a company which engages in the research, development, and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations